Santos A. Susin

Dr. Santos A. Susin

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1999 in Nature
Verified
Journal Article
Closed access
PDF file
SSSantos A. Susin
Santos A. Susin
HLHans-Kristian Lorenzo
Hans-Kristian Lorenzo
NZNaoufal Zamzami
Naoufal Zamzami
IMIsabel Marzo
Isabel Marzo
BSBryan E. Snow
Bryan E. Snow
Guido KroemerGuido Kroemer
Guido Kroemer

1 August 1995 in Journal of Experimental Medicine
Verified
Journal Article
Open access
NZN Zamzami
N Zamzami
PMPhilippe Marchetti
Philippe Marchetti
MCM Castedo
M Castedo
DDD Decaudin
D Decaudin
AMA Macho
A Macho
Guido KroemerGuido Kroemer
Guido Kroemer
Programmed cell death (PCD) is a physiological process commonly defined by alterations in nuclear morphology (apoptosis) and/or characteristic stepwise degradation of chromosomal DNA occurring before cytolysis. However, determined characteristics of PCD such as loss in mitochondrial reductase activity or cytolysis can be induced in enucleated cells, indicating cytoplasmic PCD control. Here we report a sequential disregulation of mitochondrial function that precedes cell shrinkage and nuclear fragmentation. A first cyclosporin A-inhibitable step of ongoing PCD is characterized by a reduction of mitochondrial transmembrane potential, as determined by specific fluorochromes (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine++ + iodide; 3,3'dihexyloxacarbocyanine iodide). Cytofluorometrically purified cells with reduced mitochondrial transmembrane potential are initially incapable of oxidizing hydroethidine (HE) into ethidium. Upon short-term in vitro culture, such cells acquire the capacity of HE oxidation, thus revealing a second step of PCD marked by mitochondrial generation of reactive oxygen species (ROS). This step can be selectively inhibited by rotenone and ruthenium red yet is not affected by cyclosporin A. Finally, cells reduce their volume, a step that is delayed by radical scavengers, indicating the implication of ROS in the apoptotic process. This sequence of alterations accompanying early PCD is found in very different models of apoptosis induction: glucocorticoid-induced death of lymphocytes, activation-induced PCD of T cell hybridomas, and tumor necrosis factor-induced death of U937 cells. Transfection with the antiapoptotic protooncogene Bcl-2 simultaneously inhibits mitochondrial alterations and apoptotic cell death triggered by steroids or ceramide. In vivo injection of fluorochromes such as 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide; 3,3'dihexyloxacarbocyanine iodide; or HE allows for the detection of cells that are programmed for death but still lack nuclear DNA fragmentation. In particular, assessment of mitochondrial ROS generation provides an accurate picture of PCD-mediated lymphocyte depletion. In conclusion, alterations of mitochondrial function constitute an important feature of early PCD.

1 March 2001 in Nature
Verified
Journal Article
Closed access
PDF file
NJNicholas Joza
Nicholas Joza
SSSantos A. Susin
Santos A. Susin
EDEric Daugas
Eric Daugas
WSWilliam L. Stanford
William L. Stanford
SCSarah K. Cho
Sarah K. Cho
JPJosef M Penninger
Josef M Penninger

1 April 1996 in Journal of Experimental Medicine
Verified
Journal Article
Open access
NZN Zamzami
N Zamzami
SSSantos A. Susin
Santos A. Susin
PMPhilippe Marchetti
Philippe Marchetti
THT Hirsch
T Hirsch
IGI Gómez-Monterrey
I Gómez-Monterrey
Guido KroemerGuido Kroemer
Guido Kroemer
Anucleate cells can be induced to undergo programmed cell death (PCD), indicating the existence of a cytoplasmic PCD pathway that functions independently from the nucleus. Cytoplasmic structures including mitochondria have been shown to participate in the control of apoptotic nuclear disintegration. Before cells exhibit common signs of nuclear apoptosis (chromatin condensation and endonuclease-mediated DNA fragmentation), they undergo a reduction of the mitochondrial transmembrane potential (delta psi m) that may be due to the opening of mitochondrial permeability transition (PT) pores. Here, we present direct evidence indicating that mitochondrial PT constitutes a critical early event of the apoptotic process. In a cell-free system combining purified mitochondria and nuclei, mitochondria undergoing PT suffice to induce chromatin condensation and DNA fragmentation. Induction of PT by pharmacological agents augments the apoptosis-inducing potential of mitochondria. In contrast, prevention of PT by pharmacological agents impedes nuclear apoptosis, both in vitro and in vivo. Mitochondria from hepatocytes or lymphoid cells undergoing apoptosis, but not those from normal cells, induce disintegration of isolated Hela nuclei. A specific ligand of the mitochondrial adenine nucleotide translocator (ANT), bongkreik acid, inhibits PT and reduces apoptosis induction by mitochondria in a cell-free system. Moreover, it inhibits the induction of apoptosis in intact cells. Several pieces of evidence suggest that the proto-oncogene product Bcl-2 inhibits apoptosis by preventing mitochondrial PT. First, to inhibit nuclear apoptosis, Bcl-2 must be localized in mitochondrial but not nuclear membranes. Second, transfection-enforced hyperexpression of Bcl-2 directly abolishes the induction of mitochondrial PT in response to a protonophore, a pro-oxidant, as well as to the ANT ligand atractyloside, correlating with its apoptosis-inhibitory effect. In conclusion, mitochondrial PT appears to be a critical step of the apoptotic cascade.

1 January 1997 in Immunology Today
Verified
Journal Article
Closed access
GKGuido Kroemer
Guido Kroemer
NZNaoufal Zamzami
Naoufal Zamzami
SSSantos A. Susin
Santos A. Susin

25 September 1998 in Science
Verified
Journal Article
Closed access
PDF file
IMIsabel Marzo
Isabel Marzo
CBCatherine Brenner
Catherine Brenner
NZNaoufal Zamzami
Naoufal Zamzami
JJJuliane M. JürGensmeier
Juliane M. JürGensmeier
SSSantos A. Susin
Santos A. Susin
GKGuido Kroemer
Guido Kroemer
The proapoptotic Bax protein induces cell death by acting on mitochondria. Bax binds to the permeability transition pore complex (PTPC), a composite proteaceous channel that is involved in the regulation of mitochondrial membrane permeability. Immunodepletion of Bax from PTPC or purification of PTPC from Bax-deficient mice yielded a PTPC that could not permeabilize membranes in response to atractyloside, a proapoptotic ligand of the adenine nucleotide translocator (ANT). Bax and ANT coimmunoprecipitated and interacted in the yeast two-hybrid system. Ectopic expression of Bax induced cell death in wild-type but not in ANT-deficient yeast. Recombinant Bax and purified ANT, but neither of them alone, efficiently formed atractyloside-responsive channels in artificial membranes. Hence, the proapoptotic molecule Bax and the constitutive mitochondrial protein ANT cooperate within the PTPC to increase mitochondrial membrane permeability and to trigger cell death.